186 related articles for article (PubMed ID: 19199361)
21. Weight change in Parkinson and Alzheimer patients taking atypical antipsychotic drugs.
Sitburana O; Rountree S; Ondo WG
J Neurol Sci; 2008 Sep; 272(1-2):77-82. PubMed ID: 18556024
[TBL] [Abstract][Full Text] [Related]
22. Low plasma uric acid level in Parkinson's disease.
Annanmaki T; Muuronen A; Murros K
Mov Disord; 2007 Jun; 22(8):1133-7. PubMed ID: 17443703
[TBL] [Abstract][Full Text] [Related]
23. Avoidance of solid food in weight losing older patients with Parkinson's disease.
Lorefält B; Granérus AK; Unosson M
J Clin Nurs; 2006 Nov; 15(11):1404-12. PubMed ID: 17038101
[TBL] [Abstract][Full Text] [Related]
24. Changes of functional connectivity of the motor network in the resting state in Parkinson's disease.
Wu T; Wang L; Chen Y; Zhao C; Li K; Chan P
Neurosci Lett; 2009 Aug; 460(1):6-10. PubMed ID: 19463891
[TBL] [Abstract][Full Text] [Related]
25. Body fat distribution in Parkinson's disease: An MRI-based body fat quantification study.
Bernhardt D; Müller HP; Ludolph AC; Dupuis L; Kassubek J
Parkinsonism Relat Disord; 2016 Dec; 33():84-89. PubMed ID: 27665038
[TBL] [Abstract][Full Text] [Related]
26. Pain intensity on and off levodopa in patients with Parkinson's disease.
Nebe A; Ebersbach G
Mov Disord; 2009 Jun; 24(8):1233-7. PubMed ID: 19412949
[TBL] [Abstract][Full Text] [Related]
27. Influence of subthalamic deep brain stimulation versus levodopa on motor perseverations in Parkinson's disease.
Herzog J; Möller B; Witt K; Pinsker MO; Deuschl G; Volkmann J
Mov Disord; 2009 Jun; 24(8):1206-10. PubMed ID: 19412937
[TBL] [Abstract][Full Text] [Related]
28. Gait and balance disorders in Parkinson's disease: impaired active braking of the fall of centre of gravity.
Chastan N; Do MC; Bonneville F; Torny F; Bloch F; Westby GW; Dormont D; Agid Y; Welter ML
Mov Disord; 2009 Jan; 24(2):188-95. PubMed ID: 18973252
[TBL] [Abstract][Full Text] [Related]
29. Weight change affects serum leptin and corticosterone in the collared lemming.
Johnson MS; Onorato DP; Gower BA; Nagy TR
Gen Comp Endocrinol; 2004 Mar; 136(1):30-6. PubMed ID: 14980794
[TBL] [Abstract][Full Text] [Related]
30. The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies.
Leentjens AF; Koester J; Fruh B; Shephard DT; Barone P; Houben JJ
Clin Ther; 2009 Jan; 31(1):89-98. PubMed ID: 19243709
[TBL] [Abstract][Full Text] [Related]
31. Low leptin levels in migraine: a case control study.
Guldiken B; Guldiken S; Demir M; Turgut N; Tugrul A
Headache; 2008 Jul; 48(7):1103-7. PubMed ID: 18547265
[TBL] [Abstract][Full Text] [Related]
32. [Fatigue and weight loss in Parkinson's disease].
Okuma Y
Brain Nerve; 2012 Apr; 64(4):384-93. PubMed ID: 22481511
[TBL] [Abstract][Full Text] [Related]
33. Slow recovery of body fat lost during adenovirus-induced hyperleptinemia.
Higa M; Kakuma T; Pan W; Wang ZW; Babcock E; McCorkle K; Lee Y; Unger R
Biochem Biophys Res Commun; 2000 Dec; 279(3):786-91. PubMed ID: 11162429
[TBL] [Abstract][Full Text] [Related]
34. Long-term weight loss decreases the nontraditional cardiovascular risk factors interleukin-18 and matrix metalloproteinase-9 in obese subjects.
Madsen EL; Bruun JM; Skogstrand K; Hougaard DM; Christiansen T; Richelsen B
Metabolism; 2009 Jul; 58(7):946-53. PubMed ID: 19409578
[TBL] [Abstract][Full Text] [Related]
35. Body fat predicts an increase and limb muscle strength predicts a decrease in leptin in older adults over 2·6 years.
Antony B; Jones G; Stannus O; Blizzard L; Ding C
Clin Endocrinol (Oxf); 2013 Nov; 79(5):652-60. PubMed ID: 23146120
[TBL] [Abstract][Full Text] [Related]
36. Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia.
Zoccolella S; dell'Aquila C; Abruzzese G; Antonini A; Bonuccelli U; Canesi M; Cristina S; Marchese R; Pacchetti C; Zagaglia R; Logroscino G; Defazio G; Lamberti P; Livrea P
Mov Disord; 2009 May; 24(7):1028-33. PubMed ID: 19353704
[TBL] [Abstract][Full Text] [Related]
37. Body weight in patients with Parkinson's disease.
Bachmann CG; Trenkwalder C
Mov Disord; 2006 Nov; 21(11):1824-30. PubMed ID: 16958133
[TBL] [Abstract][Full Text] [Related]
38. Cysteine elevation in levodopa-treated patients with Parkinson's disease.
Müller T; Kuhn W
Mov Disord; 2009 Apr; 24(6):929-32. PubMed ID: 19243072
[TBL] [Abstract][Full Text] [Related]
39. Degree of weight loss required to improve adipokine concentrations and decrease fat cell size in severely obese women.
Varady KA; Tussing L; Bhutani S; Braunschweig CL
Metabolism; 2009 Aug; 58(8):1096-101. PubMed ID: 19477470
[TBL] [Abstract][Full Text] [Related]
40. The effect of reduction of the peripheral fat content by liposuction-assisted lipectomy (SAL) on serum leptin levels in the postoperative period: a prospective study.
Talisman R; Belinson N; Modan-Moses D; Canti H; Orenstein A; Barzilai Z; Parret G
Aesthetic Plast Surg; 2001; 25(4):262-5. PubMed ID: 11568828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
